Form4insider filings, from the source

SEC Form 4 · accession 0001012975-15-000645

Sage Therapeutics, Inc. · SAGE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Kevin P Starr
Director · 10% Owner
Period of report
Aug 18, 2015
Accepted (ET)
Aug 18, 2015 · 4:33 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001597553

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2Aug 18, 2015J2,330,157$0.00D6,442,916ISee footnote
Common StockF4Aug 18, 2015J150,546$0.00A150,546ISee footnote
Common StockF4Aug 18, 2015J150,546$0.00D0ISee footnote
Common StockAug 18, 2015J21,910$0.00A49,241D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses